Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical Prostatectomy From August 1996 through October 2002, eight patients with advanced MF/SS underwent allogeneic ...
SAN DIEGO, April 17, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), a global leader in the transformation of the cytogenetic workflow with OGM, today announced that it has entered into an ...
SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform for ...
In the Department of Genetics, doctors are using genetic and genomic testing to pinpoint the exact cause of a patient’s condition—even when symptoms mimic more than one disorder. This clarity is ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Life sciences company Bionano (BNGO) has drawn a lot of attention this year due its potential to disrupt the cytogenetics field - the study of chromosomes. Bionano’s optical genome mapping (OGM) ...
Traditional cytogenetic techniques for the macro-analysis of chromosomal structure often preclude high-resolution visualization of specific genomic regions. Accordingly, researchers are increasingly ...
The Northern Ireland Regional Molecular Diagnostics Service (RMDS) has relied traditionally on cytogenetic techniques such as karyotyping, fluorescent in situ hybridisation (FISH) and SNP Array to ...
Bionano, a global leader in the transformation of the cytogenetic workflow with optical genome mapping (OGM), has entered into a strategic partnership with Hangzhou Diagens Biotechnology Co., Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results